Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-30

FDA Approved: CANDESARTAN CILEXETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for candesartan cilexetil from Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • candesartan cilexetil (candesartan cilexetil)

Snippet

SUPPL AP for CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL)